alpha-Tocopherol induces hematopoietic stem/progenitor cell expansion and ERK1/2-mediated differentiation

• Autor(a) principal: Nogueira-Pedro, Amanda [UNIFESP]
• Data de Publicação: 2011
• Outros Autores: Barbosa, Christiano Marcello Vaz [UNIFESP], Segreto, Helena Regina Comodo [UNIFESP], Lungato, Lisandro [UNIFESP], D'Almeida, Vania [UNIFESP], Moraes, Andrea Aparecida Fátima Souza [UNIFESP], Miranda, Antonio [UNIFESP], Paredes-Gamero, Edgar Julian [UNIFESP], Ferreira, Alice Teixeira [UNIFESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNIFESP
• dARK ID: ark:/48912/0013000000gmt
• Texto Completo: https://dx.doi.org/10.1189/jlb.0611282; https://repositorio.unifesp.br/handle/11600/34261
• topic: Proliferation; IL-3; Monocyte; Granulocyte

Tocopherols promote or inhibit growth in different cell types. in the hematopoietic system, the radioprotective property of tocopherols is thought to act through the expansion of primitive hematopoietic cells. However, the mechanisms activated by tocopherols and which HPs are affected remain poorly understood. To better address these questions, mice were treated with alpha-tocopherol, and its effects were investigated in the BM microenvironment. alpha-Tocopherol induced increased proliferation in HSC/HP cells, leading to BM hyperplasia. in addition, differentiation to the granulocytic/monocytic lineage was enhanced by alpha-tocopherol treatment. alpha-Tocopherol treatment resulted in decreased basal phosphorylation of ERK1/2, PKC, and STAT-5 in HSC/HP cells. in contrast, alpha-tocopherol enhanced ERK1/2 activation in response to IL-3 stimulation in HSC/HP cells without altering the expression of IL-3Rs. Moreover, alpha-tocopherol-induced differentiation and ERK1/2 activation were abolished in mice pretreated with a MEK inhibitor (PD98059); however, pretreatment with PD98059 did not reduce the alpha-tocopherol-mediated increase in HSC/HP cells but instead, further enhanced their proliferation. Therefore, alpha-tocopherol induces expansion of HSC/HP cells by a nonidentified intracellular pathway and granulocytic/monocytic differentiation through ERK1/2 activation. J. Leukoc. Biol. 90: 1111-1117; 2011.